WO2014102643A1 - Novel use of canthaxanthin and 25-hydroxy vitamin d3 - Google Patents
Novel use of canthaxanthin and 25-hydroxy vitamin d3 Download PDFInfo
- Publication number
- WO2014102643A1 WO2014102643A1 PCT/IB2013/060844 IB2013060844W WO2014102643A1 WO 2014102643 A1 WO2014102643 A1 WO 2014102643A1 IB 2013060844 W IB2013060844 W IB 2013060844W WO 2014102643 A1 WO2014102643 A1 WO 2014102643A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- vitamin
- canthaxanthin
- poultry
- maxichick
- ppm
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/174—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/105—Aliphatic or alicyclic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/179—Colouring agents, e.g. pigmenting or dyeing agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
- A23K50/75—Feeding-stuffs specially adapted for particular animals for birds for poultry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
Definitions
- the present invention relates to the use of canthaxanthin and at least one vitamin D metabolite, preferably 25-hydroxy vitamin D3 (25-OH D3), for improving broiler performance. More particularly the invention relates to the use of canthaxanthin and 25- hydroxy vitamin D3 in the manufacture of a feed composition for improving weight gain in poultry broilers and increasing carcass ratio of poultry meet.
- feed intake, weight gain and feed conversion ratio can be improved in poultry broilers by administering to the animals an effective amount of Canthaxanthin and 25-OH-D3.
- Tritsch et al. disclose a feed premix composition of at least 25-OH D3 in an amount between 5% and 50% (wt/wt) dissolved in oil and an antioxidant, an agent encapsulating droplets of 25-OH D3 and oil, and a nutritional additive (e.g., Vitamin D3).
- the premix may be added to poultry, swine, canine, or feline food. This composition stabilizes 25-OH D3 against oxidation.
- Simoes-Nunes et al. discloses adding a combination of 25-OH Vitamin D3 and Vitamin D3 to animal feed.
- about 10 ⁇ g/kg to about 100 ⁇ g/kg of 25-OH Vitamin D3 and about 200 lU/kg to about 4,000 lU/kg of Vitamin D3 are added to swine feed. This addition improves the pig's bone strength.
- Stark et al. disclose adding a combination of 25-OH Vitamin D3 and Vitamin D3 to poultry feed to ameliorate the effects of tibial dyschondroplasia.
- Borenstein et al US 5,043,170 discloses the combination of Vitamin D3 and either 1 - alpha-hydroxycholecalciferol or 1 alpha, 25-dihydroxycholecalciferol to improve egg strength and leg strength in laying hens and older hens.
- Fleshner-Barak discloses administration of bisphosphonate compound and natural vitamin D derivative such as 1 ,25-dihydroxyvitamin D3 or 24,25- dihydroxyvitamin D3, or 25-OH vitamin D3.
- Daifotis et al. disclose inhibiting bone resorption by a combination of at least one bisphosphonate compound and from about 100 IU to about 60,000 IU of a no activated metabolite of vitamin D2 and/or vitamin D3.
- the aforementioned documents did not teach or suggest that the use of canthaxanthin and 25-OH D3 would be surprisingly beneficial for improving feed intake, weight gain and feed conversion ratio in poultry broilers.
- Vitamin D metabolite means any metabolite of Vitamin D as for example 25-hydroxy vitamin D3, 1 ,25-dihydroxy vitamin D3 or 24,25-dihydroxy vitamin D3.
- 25-OH D3 refers specifically to 25-hydroxy vitamin D3.
- Pesttry is meant to include turkeys, ducks and chickens (including but not limited to broiler chicks, layers, breeders).
- Canthaxanthin and 25-OH D3 may be obtained from any source, and a composition thereof may be prepared using convenient technology.
- carcass means the body of an animal, that has been slaughtered for food, with the head, limbs, and entrails removed.
- carcass ratio is determined on the basis of the body weight that has been slaughtered for food, with the head, limbs, and entrails removed and of the body weight of the animal before slaughtering.
- one or more feed compositions suitable for poultry use are provided to administer canthaxanthin and 25-OH D3 as nutrients to improve weight gain in poultry broilers.
- one or more feed compositions suitable for poultry use are provided to administer canthaxanthin and 25-OH D3 as nutrients to increase carcass ratio in poultry animals.
- a poultry feed which comprises from about 10 ⁇ g/kg to about 100 ⁇ g/kg of 25-OH D3 and from about 2 to 100 ppm canthaxanthin, preferably 2 to 10 ppm.
- a method of administering canthaxanthin and 25-OH D3 to poultry broilers is provided to improve weight gain and carcass ratio in poultry animals, e.g. broilers.
- the method comprises administering to the animal in need of such treatment an amount of about 2 ppm to 100 ppm of canthaxanthin, preferably 2 to 10 ppm, and about 10 ⁇ g/kg to about 100 ⁇ g/kg of 25-OH D3.
- a premix composition for poultry feed comprising 25-hydroxy vitamin D3 and canthaxanthin.
- Canthaxanthin and 25-hydroxy vitamin D3 are suitably administered together with the food.
- the term food as used herein comprises both solid and liquid food as well as drinking fluids such as drinking water.
- inventive ingredients can be added as a formulated powder to a premix containing other minerals, vitamins, amino acids and trace elements which is added to regular animal food and thorough mixing to achieve even distribution therein.
- a food premix may be prepared on the basis of regular food components by adding these active ingredients to such food components in higher concentration.
- the 25-OH-D3 compound is available under the Trademark ROVIMIX® Hy-D® 1 .25 % and canthaxanthin under the Trademark
- CAROPHYLL®Red A combination product of both, canthaxanthin and 25-OH-D3 is available under the Trademark MAXICHICK®.
- composition also contains one or more of the following ingredients: Vitamin A, Vitamin E, Biotin, copper (e.g. as CuS0 4 ), zinc (e.g. as ZnS0 4 ), cobalt (e.g. as CoS0 4 ), selenium (e.g. as
- Na 2 Se0 3 Na 2 Se0 3
- iodine e.g. as Kl
- manganese e.g. as MnS0 4
- calcium e.g. as CaS0 4
- Example 1 Effect of Carophyll Red (Canthaxanthin) and 25-OH D3 on feed intake, weight gain and feed conversion ratio of poultry broilers.
- the trial had three stages at three different ages: 35, 45 and 55 weeks.
- the diet given to the birds was a standard feed for broiler chickens with the addition of the products that were tested.
- the feed met all nutritional requirements in relation to the developmental stage of the birds and the recommendations in the breeders' guide.
- the feed was entirely vegetable-based, using corn and Soya bran (An example of a premix diet without Maxichick is given in Table 7).
- the experimental design was entirely random, with two treatments and six groups of 30 female and 3 male chickens.
- Weight gain, feed intake and feed conversion ratio was calculated according methods known to the person skilled in the art.
- Vitamin B6 950 mg Nutrient Quantity per kilo of product Unit
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Health & Medical Sciences (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Fodder In General (AREA)
- Feed For Specific Animals (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
Claims
Priority Applications (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201380068049.4A CN104869842A (en) | 2012-12-27 | 2013-12-12 | Novel use of canthaxanthin and 25-hydroxy vitamin D3 |
| US14/655,115 US20150342222A1 (en) | 2012-12-27 | 2013-12-12 | Novel use of canthaxanthin and 25-hydroxy vitamin d3 |
| AU2013369010A AU2013369010A1 (en) | 2012-12-27 | 2013-12-12 | Novel use of canthaxanthin and 25-hydroxy vitamin D3 |
| BR112015020074A BR112015020074A2 (en) | 2012-12-27 | 2013-12-12 | new use of canthaxanthin and 25-hydroxy vitamin d3 |
| EP13840175.7A EP2938205A1 (en) | 2012-12-27 | 2013-12-12 | Novel use of canthaxanthin and 25-hydroxy vitamin d3 |
| MX2015008262A MX2015008262A (en) | 2012-12-27 | 2013-12-12 | Novel use of canthaxanthin and 25-hydroxy vitamin d3. |
| US15/437,873 US20170156370A1 (en) | 2012-12-27 | 2017-02-21 | Novel use of canthaxanthin and 25-hydroxy vitamin d3 |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12199398 | 2012-12-27 | ||
| EP12199398.4 | 2012-12-27 | ||
| EP13170040.3 | 2013-05-31 | ||
| EP13170040 | 2013-05-31 |
Related Child Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US14/655,115 A-371-Of-International US20150342222A1 (en) | 2012-12-27 | 2013-12-12 | Novel use of canthaxanthin and 25-hydroxy vitamin d3 |
| US15/437,873 Continuation US20170156370A1 (en) | 2012-12-27 | 2017-02-21 | Novel use of canthaxanthin and 25-hydroxy vitamin d3 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2014102643A1 true WO2014102643A1 (en) | 2014-07-03 |
Family
ID=50349656
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/IB2013/060844 Ceased WO2014102643A1 (en) | 2012-12-27 | 2013-12-12 | Novel use of canthaxanthin and 25-hydroxy vitamin d3 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US20150342222A1 (en) |
| EP (1) | EP2938205A1 (en) |
| CN (1) | CN104869842A (en) |
| AU (1) | AU2013369010A1 (en) |
| BR (1) | BR112015020074A2 (en) |
| MX (1) | MX2015008262A (en) |
| WO (1) | WO2014102643A1 (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014191153A1 (en) * | 2013-05-31 | 2014-12-04 | Dsm Ip Assets B.V. | Feed supplement and its use |
| US11040045B2 (en) | 2015-01-15 | 2021-06-22 | Dsm Ip Assets B.V. | Combination of 25-hydroxyvitamin D and antioxidants/anti-inflammatories for human nutraceuticals |
| US12048313B2 (en) | 2015-01-15 | 2024-07-30 | Dsm Ip Assets B.V. | Combination of 25-hydroxyvitamin D and antioxidants/anti-inflammatories for poultry ovarian health |
Citations (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5043170A (en) | 1989-02-14 | 1991-08-27 | Hoffmann-La Roche Inc. | Animal feed composition containing a vitamin D metabolite |
| US5695794A (en) | 1995-08-10 | 1997-12-09 | Amoco Corporation | Use of 25-hydroxycholecalciferol in a dietary supplement process for ameliorating the effects of tibial dyschondroplasia in poultry while maintaining weight gain |
| WO2003007916A1 (en) | 2001-07-17 | 2003-01-30 | Teva Pharmaceutical Industries Ltd. | Dosage forms for immediate gastric release of a calcium transport stimulator coupled with delayed gastric release of a bis-phosphonate |
| US20030170324A1 (en) | 2002-01-15 | 2003-09-11 | Jean-Claude Tritsch | 25-Hydroxy Vitamin D3 compositions |
| WO2003086415A1 (en) | 2002-04-05 | 2003-10-23 | Merck & Co., Inc. | Method for inhibiting bone resorption with an alendronate and vitamin d formulation |
| US20050064018A1 (en) | 2003-09-22 | 2005-03-24 | Carlos Simoes-Nunes | Use of vitamin D compounds |
| WO2009141380A1 (en) * | 2008-05-22 | 2009-11-26 | Dsm Ip Assets B.V. | Novel use of canthaxanthin |
| WO2010057811A2 (en) * | 2008-11-19 | 2010-05-27 | Dsm Ip Assets B.V. | Use of canthaxanthin and/or 25-oh d3 for improved hatchability in poultry |
| WO2011015651A1 (en) * | 2009-08-07 | 2011-02-10 | Dsm Ip Assets B.V. | Use of canthaxanthin compounds |
| WO2011076557A1 (en) * | 2009-12-22 | 2011-06-30 | Dsm Ip Assets B.V. | Use of canthaxanthin and/or 25-oh d3 for improved reproductivity and performance of roosters |
| WO2013174148A1 (en) * | 2012-05-25 | 2013-11-28 | Dsm Ip Assets B.V. | Method for improving growth performance and/or bone performance of animal |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100581383C (en) * | 2006-11-03 | 2010-01-20 | 朱福康 | High quality yellow feather broiler compound feed |
-
2013
- 2013-12-12 WO PCT/IB2013/060844 patent/WO2014102643A1/en not_active Ceased
- 2013-12-12 AU AU2013369010A patent/AU2013369010A1/en not_active Abandoned
- 2013-12-12 EP EP13840175.7A patent/EP2938205A1/en not_active Withdrawn
- 2013-12-12 MX MX2015008262A patent/MX2015008262A/en unknown
- 2013-12-12 BR BR112015020074A patent/BR112015020074A2/en not_active Application Discontinuation
- 2013-12-12 US US14/655,115 patent/US20150342222A1/en not_active Abandoned
- 2013-12-12 CN CN201380068049.4A patent/CN104869842A/en active Pending
-
2017
- 2017-02-21 US US15/437,873 patent/US20170156370A1/en not_active Abandoned
Patent Citations (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5043170A (en) | 1989-02-14 | 1991-08-27 | Hoffmann-La Roche Inc. | Animal feed composition containing a vitamin D metabolite |
| US5695794A (en) | 1995-08-10 | 1997-12-09 | Amoco Corporation | Use of 25-hydroxycholecalciferol in a dietary supplement process for ameliorating the effects of tibial dyschondroplasia in poultry while maintaining weight gain |
| WO2003007916A1 (en) | 2001-07-17 | 2003-01-30 | Teva Pharmaceutical Industries Ltd. | Dosage forms for immediate gastric release of a calcium transport stimulator coupled with delayed gastric release of a bis-phosphonate |
| US20030170324A1 (en) | 2002-01-15 | 2003-09-11 | Jean-Claude Tritsch | 25-Hydroxy Vitamin D3 compositions |
| WO2003086415A1 (en) | 2002-04-05 | 2003-10-23 | Merck & Co., Inc. | Method for inhibiting bone resorption with an alendronate and vitamin d formulation |
| US20050064018A1 (en) | 2003-09-22 | 2005-03-24 | Carlos Simoes-Nunes | Use of vitamin D compounds |
| WO2009141380A1 (en) * | 2008-05-22 | 2009-11-26 | Dsm Ip Assets B.V. | Novel use of canthaxanthin |
| WO2010057811A2 (en) * | 2008-11-19 | 2010-05-27 | Dsm Ip Assets B.V. | Use of canthaxanthin and/or 25-oh d3 for improved hatchability in poultry |
| WO2011015651A1 (en) * | 2009-08-07 | 2011-02-10 | Dsm Ip Assets B.V. | Use of canthaxanthin compounds |
| WO2011076557A1 (en) * | 2009-12-22 | 2011-06-30 | Dsm Ip Assets B.V. | Use of canthaxanthin and/or 25-oh d3 for improved reproductivity and performance of roosters |
| WO2013174148A1 (en) * | 2012-05-25 | 2013-11-28 | Dsm Ip Assets B.V. | Method for improving growth performance and/or bone performance of animal |
Non-Patent Citations (1)
| Title |
|---|
| C. A. LOZANO ET AL: "Poultry Science Association 102nd Annual Meeting", EFFECTS OF DIETARY 25-HYDROXY VITAMIN D3 AND CANTHAXANTHIN ON COMMERCIAL BROILERS IN COLOMBIA, 22 July 2013 (2013-07-22) - 25 July 2013 (2013-07-25), pages 41 - 42, XP055118235 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014191153A1 (en) * | 2013-05-31 | 2014-12-04 | Dsm Ip Assets B.V. | Feed supplement and its use |
| US11040045B2 (en) | 2015-01-15 | 2021-06-22 | Dsm Ip Assets B.V. | Combination of 25-hydroxyvitamin D and antioxidants/anti-inflammatories for human nutraceuticals |
| US12048313B2 (en) | 2015-01-15 | 2024-07-30 | Dsm Ip Assets B.V. | Combination of 25-hydroxyvitamin D and antioxidants/anti-inflammatories for poultry ovarian health |
Also Published As
| Publication number | Publication date |
|---|---|
| CN104869842A (en) | 2015-08-26 |
| AU2013369010A1 (en) | 2015-07-16 |
| MX2015008262A (en) | 2015-09-29 |
| US20170156370A1 (en) | 2017-06-08 |
| EP2938205A1 (en) | 2015-11-04 |
| BR112015020074A2 (en) | 2019-11-26 |
| US20150342222A1 (en) | 2015-12-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Peng et al. | Effects of dietary supplementation with oregano essential oil on growth performance, carcass traits and jejunal morphology in broiler chickens | |
| US20230059330A1 (en) | Encapsulation of nutritional and/or compounds for controlled release and enhancing their bioavailability by limiting chemical or microbial exposure | |
| Awaad et al. | Effect of a specific combination of carvacrol, cinnamaldehyde, and Capsicum oleoresin on the growth performance, carcass quality and gut integrity of broiler chickens | |
| CA2737680C (en) | Use of canthaxanthin and/or 25-oh d3 for improved hatchability in poultry | |
| Henn et al. | Inclusion of porcine spray-dried plasma in broiler diets | |
| Levkut et al. | The effect of inorganic or organic zinc on the morphology of the intestine in broiler chickens | |
| TW201402010A (en) | Treatment of poultry, pigs or fish for reducing the feed conversion ratio or increasing their bodyweight gain | |
| KR20100080781A (en) | Treatment of pigs for reducing the feed conversion ratio or increasing the growth rate | |
| US20170156370A1 (en) | Novel use of canthaxanthin and 25-hydroxy vitamin d3 | |
| EP3979814A1 (en) | Use of benzoic acid and essential oil compounds for improving growth performance | |
| EP2515676A1 (en) | Use of canthaxanthin and/or 25-oh d3 for improved reproductivity and performance of roosters | |
| JP2020158488A (en) | Use of canthaxanthin for spawning hens | |
| IMARİ et al. | Effect of Calcium to Phosphorus Ratio on Tibia Mineralization, Blood Metabolites and Carcass Traits of Broiler Chickens | |
| WO2020243975A1 (en) | Use of nutraceutical composition in animal feed | |
| Shishirr et al. | Effect of organic acid addition in low protein and energy diet on the performance of broiler | |
| NZ617576B2 (en) | Use of 25-hydroxy vitamin d3 to promote phosphorous utilisation in ruminants | |
| NZ617576A (en) | Use of 25-hydroxy vitamin d3 to promote phosphorous utilisation in ruminants |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 13840175 Country of ref document: EP Kind code of ref document: A1 |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 2013840175 Country of ref document: EP |
|
| WWE | Wipo information: entry into national phase |
Ref document number: MX/A/2015/008262 Country of ref document: MX |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 14655115 Country of ref document: US |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| ENP | Entry into the national phase |
Ref document number: 2013369010 Country of ref document: AU Date of ref document: 20131212 Kind code of ref document: A |
|
| REG | Reference to national code |
Ref country code: BR Ref legal event code: B01A Ref document number: 112015020074 Country of ref document: BR |
|
| ENP | Entry into the national phase |
Ref document number: 112015020074 Country of ref document: BR Kind code of ref document: A2 Effective date: 20150629 |

